RTW Investments, LP 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 07:52 am Sale | 2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | RTW Investments, LP | 0 0.000% | -4,356,920 (Position Closed) | Filing |
| 2023-02-14 10:07 am Purchase | 2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | RTW Investments, LP | 4,356,920 9.500% | 1,375,960 (+46.16%) | Filing |
| 2022-02-14 08:39 am Purchase | 2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | RTW Investments, LP | 2,980,960 6.600% | 2,980,960 (New Position) | Filing |